{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:46:13Z","timestamp":1785840373805,"version":"3.56.0"},"reference-count":23,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14854","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T12:48:12Z","timestamp":1734698892000},"source":"Crossref","is-referenced-by-count":5,"title":["Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal <i>EWSR1::NFATC2<\/i> sarcoma: A case report"],"prefix":"10.3892","volume":"29","author":[{"given":"Tetsuya","family":"Urasaki","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Tanizawa","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Togashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ohmoto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Suto","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Tomomatsu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Hayakawa","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Ae","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135\u20118550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"key20250207091822_b1-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1200\/JCO.2014.59.5256","article-title":"Ewing sarcoma: Current management and future approaches through collaboration","volume":"33","author":"Gaspar","year":"2015","journal-title":"J Clin Oncol"},{"key":"key20250207091822_b2-ol-29-3-14854","article-title":"WHO Classification of Tumours: Soft Tissue and Bone Tumours","author":"The WHO Classification of Tumours Editorial Board","year":"2020","edition":"3.5th edition"},{"key":"key20250207091822_b3-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1158\/1078-0432.CCR-08-2184","article-title":"The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology","volume":"15","author":"Szuhai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20250207091822_b4-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/PAS.0000000000001441","article-title":"NKX3-1 is a useful immunohistochemical marker of EWSR1-NFATC2 sarcoma and mesenchymal chondrosarcoma","volume":"44","author":"Yoshida","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"key20250207091822_b5-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/modpathol.2017.49","article-title":"EWSR1 fusion proteins mediate PAX7 expression in ewing sarcoma","volume":"30","author":"Charville","year":"2017","journal-title":"Mod Pathol"},{"key":"key20250207091822_b6-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/his.13689","article-title":"PAX7 Immunohistochemical evaluation of ewing sarcoma and other small round cell tumours","volume":"73","author":"Toki","year":"2018","journal-title":"Histopathology"},{"key":"key20250207091822_b7-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/PAS.0000000000001260","article-title":"EWSR1-NFATC2 translocation-associated sarcoma clinicopathologic findings in a rare aggressive primary bone or soft tissue tumor","volume":"43","author":"Wang","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"key20250207091822_b8-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41379-020-0570-8","article-title":"NFATc2-rearranged sarcomas: Clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker","volume":"33","author":"Perret","year":"2020","journal-title":"Mod Pathol"},{"key":"key20250207091822_b9-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00428-014-1613-7","article-title":"Malignant round cell tumor of bone with EWSR1-NFATC2 gene fusion","volume":"465","author":"Sadri","year":"2014","journal-title":"Virchows Arch"},{"key":"key20250207091822_b10-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF00355396","article-title":"Case report 235. Ewing-like adamantinoma of the left radial head and neck","volume":"10","author":"Lipper","year":"1983","journal-title":"Skeletal Radiol"},{"key":"key20250207091822_b11-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/pin.13135","article-title":"Skeletal EWSR1-NFATC2 sarcoma previously diagnosed as ewing-like adamantinoma: A case report and literature review emphasizing its unique radiological features","volume":"71","author":"Makise","year":"2021","journal-title":"Pathol Int"},{"key":"key20250207091822_b12-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41698-021-00177-0","article-title":"Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target","volume":"5","author":"Seligson","year":"2021","journal-title":"NPJ Prec Oncol"},{"key":"key20250207091822_b13-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/path.5053","article-title":"Transcriptomic definition of molecular subgroups of small round cell sarcomas","volume":"245","author":"Watson","year":"2018","journal-title":"J Pathol"},{"key":"key20250207091822_b14-ol-29-3-14854","first-page":"300680","article-title":"EWSR1: NFATC2-rearranged sarcoma in bone-case report and review of the literature","volume":"30","author":"Shaheen","year":"2022","journal-title":"Hum Pathol"},{"key":"key20250207091822_b15-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.humpath.2019.05.001","article-title":"EWSR1\/FUS-NFATc2 rearranged round cell sarcoma: Clinicopathological series of 4 cases and literature review","volume":"90","author":"Diaz-Perez","year":"2019","journal-title":"Hum Pathol"},{"key":"key20250207091822_b16-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"9386390","DOI":"10.1155\/2019\/9386390","article-title":"EWSR1-NFATC2 and FUS-NFATC2 gene fusion-associated mesenchymal tumors: Clinicopathologic correlation and literature review","volume":"2019","author":"Bode-Lesniewska","year":"2019","journal-title":"Sarcoma"},{"key":"key20250207091822_b17-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/gcc.22857","article-title":"The clinical heterogeneity of round cell sarcomas with EWSR1\/FUS gene fusions: Impact of gene fusion type on clinical features and outcome","volume":"59","author":"Tsuda","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"key20250207091822_b18-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"44","DOI":"10.18632\/oncoscience.587","article-title":"Activity of pazopanib in EWSR1-NFATC2 translocation associated bone sarcoma","volume":"10","author":"Gouda","year":"2023","journal-title":"Oncoscience"},{"key":"key20250207091822_b19-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1177\/10668969241228294","article-title":"Clinicopathological features of three rare EWSR1::NFATC2 sarcomas of bone and soft tissues","volume":"32","author":"Kosemehmetoglu","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"key20250207091822_b20-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1470-2045(15)70098-7","article-title":"Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: A randomized, open-label, phase 2 study","volume":"16","author":"Kawai","year":"2015","journal-title":"Lancet Oncol"},{"key":"key20250207091822_b21-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.21873\/invivo.11644","article-title":"Retrospective analysis of trabectedin therapy for soft tissue sarcoma","volume":"33","author":"Kawaguchi","year":"2019","journal-title":"In Vivo"},{"key":"key20250207091822_b22-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/cncr.32661","article-title":"Efficacy and safety of trabectedin for patients with unresectable and relapsed soft-tissue sarcoma in Japan: A Japanese musculoskeletal oncology group study","volume":"126","author":"Kobayashi","year":"2020","journal-title":"Cancer"},{"key":"key20250207091822_b23-ol-29-3-14854","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.path.2023.07.001","article-title":"Sarcomas with EWSR1::Non-ETS fusion (EWSR1::NFATC2 and EWSR1::PATZ1)","volume":"17","author":"Machado","year":"2024","journal-title":"Surg Pathol Clin"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T07:18:27Z","timestamp":1738912707000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,12,20]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14854","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"article-number":"108"}}